Correlation between the onset of hepatic disease and reduced circulating adiponectin levels, decreased expression of adiponectin receptors, and impaired adiponectin-mediated signaling is shown in several animal models of hepatic syndromes (165). This evidence concerns the gene ADIPOQ and liver disorder.